Related references
Note: Only part of the references are listed.The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients
Ziyan Yang et al.
ONCOTARGETS AND THERAPY (2020)
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptors
Maria Vittoria Dieci et al.
CANCER TREATMENT REVIEWS (2020)
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Olga Martinez-Saez et al.
BREAST CANCER RESEARCH (2020)
A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2-Metastatic Breast Cancer
Elizabeth J. Anderson et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2020)
A Meta-analysis of the Association Between Physical Activity and Breast Cancer Mortality
Junga Lee
CANCER NURSING (2019)
Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Ling Deng et al.
CANCER RESEARCH AND TREATMENT (2019)
Cancer statistics for African Americans, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
PIK3CA in cancer: The past 30 years
Rand Arafeh et al.
SEMINARS IN CANCER BIOLOGY (2019)
Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
Zongbi Yi et al.
BMC CANCER (2019)
Akt in cancer: Mediator and more
Sundaramoorthy Revathidevi et al.
SEMINARS IN CANCER BIOLOGY (2019)
PTEN Tumor-Suppressor: The Dam of Stemness in Cancer
Francesca Luongo et al.
CANCERS (2019)
Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor-Positive Metastatic Breast Cancer The MANTA Phase 2 Randomized Clinical Trial
Peter Schmid et al.
JAMA ONCOLOGY (2019)
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives
Luisa Carbognin et al.
CANCERS (2019)
PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
Daniele Cretella et al.
CANCERS (2019)
Roles of mTOR Signaling in Tissue Regeneration
Xiangyong Wei et al.
CELLS (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Breast cancer epidemiology
Helene Sancho-Garnier et al.
PRESSE MEDICALE (2019)
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Neil Vasan et al.
SCIENCE (2019)
Rapamycin enhances the sensitivity of ER-positive breast cancer cells to tamoxifen by upregulating p73 expression
Lei Zhu et al.
ONCOLOGY REPORTS (2019)
Normal Weight Adiposity and Postmenopausal Breast Cancer Risk
Isabel Pimentel et al.
JAMA ONCOLOGY (2019)
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
Yan Xing et al.
BREAST CANCER RESEARCH (2019)
Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
Ivan Yudushkin
BIOMOLECULES (2019)
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes
Marcelo Sobral-Leite et al.
BREAST CANCER RESEARCH (2019)
The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8
Jia-jie Shi et al.
ACTA PHARMACOLOGICA SINICA (2018)
Use of dual mTOR inhibitor MLN0128 against everolimus-resistant breast cancer
Karineh Petrossian et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis
Grace H. Tang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
Ana Ruiz-Saenz et al.
CANCER RESEARCH (2018)
Breast Cancer and Ovulation Induction Treatments
Robabeh Taheripanah et al.
CLINICAL BREAST CANCER (2018)
Hormonal contraceptives and breast cancer: Clinical data
Irene Zolfaroli et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2018)
Adiposity and breast cancer risk in postmenopausal women: Results from the UK Biobank prospective cohort
Wenji Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data
Dimitrios Zardavas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Forkhead box O proteins: Crucial regulators of cancer EMT
Zhiqiang Ma et al.
SEMINARS IN CANCER BIOLOGY (2018)
Foxo transcription factors in T cell biology and tumor immunity
Chong T. Luo et al.
SEMINARS IN CANCER BIOLOGY (2018)
An overview of mammographic density and its association with breast cancer
Shayan Shaghayeq Nazari et al.
BREAST CANCER (2018)
New Insights into Protein Kinase B/Akt Signaling: Role of Localized Akt Activation and Compartment-Specific Target Proteins for the Cellular Radiation Response
Klaudia Szymonowicz et al.
CANCERS (2018)
Regulation and modulation of PTEN activity
Elahe Naderali et al.
MOLECULAR BIOLOGY REPORTS (2018)
Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Babak Nami et al.
CANCERS (2018)
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
Josefine Bostner et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Incidence and Mortality and Epidemiology of Breast Cancer in the World
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
Serum Vitamin D and Risk of Breast Cancer within Five Years
Katie M. O'Brien et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2017)
Reproductive risk factors associated with breast cancer in women in Bangui: a case-control study
Augustin Balekouzou et al.
BMC WOMENS HEALTH (2017)
Association of ABO and Rh blood groups with breast cancer
Sultan Ayoub Meo et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2017)
Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss
Kenneth Maiese
CURRENT NEUROVASCULAR RESEARCH (2017)
Breast cancer statistics, 2017, racial disparity in mortality by state
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Breast cancer risk factor evaluation in a Western Himalayan state: A case-control study and comparison with the Western World
Purnima Thakur et al.
SOUTH ASIAN JOURNAL OF CANCER (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
The Role of Forkhead Box 1 (FOXO1) in the Immune System: Dendritic Cells, T Cells, B Cells, and Hematopoietic Stem Cells
Adriana Alicia Cabrera-Ortega et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2017)
Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women
M-J Chen et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
Jonathan M. Backer
BIOCHEMICAL JOURNAL (2016)
The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu et al.
CANCER AND METASTASIS REVIEWS (2016)
Mutations in Human Interferon α2b Gene and Potential as Risk Factor Associated with Female Breast Cancer
Fayyaz Ahmed et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2016)
Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are going
Francesco Schettini et al.
CANCER TREATMENT REVIEWS (2016)
Breast Cancer Epidemiology and Risk Factors
Kristin Rojas et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2016)
Individual socioeconomic status and breast cancer diagnostic stages: a French case-control study
Mattea Orsini et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2016)
Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis
Adam Lundqvist et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2016)
Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study
Tara O. Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
Erin F. Cobain et al.
SEMINARS IN ONCOLOGY (2016)
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+breast cancer
Debora de Melo Gagliato et al.
ONCOTARGET (2016)
Insulin signaling controls neurotransmission via the 4eBP-dependent modification of the exocytotic machinery
Rebekah Elizabeth Mahoney et al.
ELIFE (2016)
Incidence and Mortality of Breast Cancer and their Relationship to Development in Asia
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2015)
Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy
Xinlei Yu et al.
AUTOPHAGY (2015)
Akt/PKB: one kinase, many modifications
Guillermo Risso et al.
BIOCHEMICAL JOURNAL (2015)
Oral Ridaforolimus Plus Trastuzumab for Patients With HER2+ Trastuzumab-Refractory Metastatic Breast Cancer
Milton Seiler et al.
CLINICAL BREAST CANCER (2015)
Night work, shift work: Breast cancer risk factor?
J. -C. Benabu et al.
GYNECOLOGIE OBSTETRIQUE & FERTILITE (2015)
Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition
Isabelle Romieu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
Stephen R. D. Johnston
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling
Laura Braccini et al.
NATURE COMMUNICATIONS (2015)
Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
Stephen R. D. Johnston
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?
Jame Abraham
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
mLST8 Promotes mTOR-Mediated Tumor Progression
Kyoko Kakumoto et al.
PLoS One (2015)
Molecular characterization and targeted therapeutic approaches in breast cancer
Angela Toss et al.
BREAST CANCER RESEARCH (2015)
The MMP-2-735 C Allele is a Risk Factor for Susceptibility to Breast Cancer
Kheirollah Yari et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
US Incidence of Breast Cancer Subtypes Defined by Joint Hormone Receptor and HER2 Status
Nadia Howlader et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
Fabrice Andre et al.
LANCET ONCOLOGY (2014)
Passive Smoking Exposure from Partners as a Risk Factor for ER plus /PR plus Double Positive Breast Cancer in Never-Smoking Chinese Urban Women: A Hospital-Based Matched Case Control Study
Jian-hua Tong et al.
PLOS ONE (2014)
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D. Lehmann et al.
BREAST CANCER RESEARCH (2014)
Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro
Nicola J. Jordan et al.
BREAST CANCER RESEARCH (2014)
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy
Sara A. Hurvitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer
Keren Merenbakh-Lamin et al.
CANCER RESEARCH (2013)
Increased expression of miR-126 and miR-10a predict prolonged relapse-free time of primary oestrogen receptor-positive breast cancer following tamoxifen treatment
Reiner Hoppe et al.
EUROPEAN JOURNAL OF CANCER (2013)
Reproductive factors and breast cancer: A case-control study in tertiary care hospital of North India
A. S. Bhadoria et al.
INDIAN JOURNAL OF CANCER (2013)
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
Rocio Garcia-Becerra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sinl phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis
Pengda Liu et al.
NATURE CELL BIOLOGY (2013)
PHOSPHOINOSITIDES: TINY LIPIDS WITH GIANT IMPACT ON CELL REGULATION
Tamas Balla
PHYSIOLOGICAL REVIEWS (2013)
New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
Elisavet Paplomata et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Phase II trial of temsirolimus in patients with metastatic breast cancer
Gini F. Fleming et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
Andrea Cavazzoni et al.
CANCER LETTERS (2012)
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency
Sigrid Hatse et al.
CARCINOGENESIS (2012)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Thomas Bachelot et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epidemiology of Breast Cancer in Europe and Africa
Ganiy Opeyemi Jnr Abdulrahman et al.
JOURNAL OF CANCER EPIDEMIOLOGY (2012)
Mechanisms of Endocrine Resistance in Breast Cancer
C. Kent Osborne et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Biological mechanisms and clinical implications of endocrine resistance in breast cancer
Mario Giuliano et al.
BREAST (2011)
Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
Carol A. Lange et al.
ENDOCRINE-RELATED CANCER (2011)
Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast Cancer
G. S. Bhattacharyya et al.
EUROPEAN JOURNAL OF CANCER (2011)
Autophagy and endocrine resistance in breast cancer
Katherine L. Cook et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review)
Sanaa Al Saleh et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Association of active and passivesmoking with risk of breast cancer among postmenopausal women: a prospective cohort study
Juhua Luo et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer
Todd W. Miller et al.
BREAST CANCER RESEARCH (2011)
New Strategies in Estrogen Receptor-Positive Breast Cancer
Stephen R. D. Johnston
CLINICAL CANCER RESEARCH (2010)
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
Sandra E. Ghayad et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort
Huiyan Ma et al.
BREAST CANCER RESEARCH (2010)
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER plus breast cancer
Chad J. Creighton et al.
BREAST CANCER RESEARCH (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
K. A. Metcalfe et al.
BRITISH JOURNAL OF CANCER (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
TORC2 Plasma Membrane Localization Is Essential for Cell Viability and Restricted to a Distinct Domain
Doris Berchtold et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition
Sabina Sieri et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
The role of phosphoinositide 3-kinase C2α in insulin signaling
Marco Falasca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women
Rulla M. Tamimi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Meat consumption and risk of breast cancer in the UK Women's Cohort Study
E. F. Taylor et al.
BRITISH JOURNAL OF CANCER (2007)
Physiological roles of PKB/Akt isoforms in development and disease
B. Dummler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Mammographic density and the risk and detection of breast cancer
Norman F. Boyd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women
A. Heather Eliassen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus
T. M. Sadler et al.
ENDOCRINE-RELATED CANCER (2006)
PIK3CA mutations in breast cancer are associated with poor outcome
SY Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Mortality rates among augmentation mammoplasty patients - An update
LA Brinton et al.
EPIDEMIOLOGY (2006)
Mutation of the PIK3CA oncogene in human cancers
B Karakas et al.
BRITISH JOURNAL OF CANCER (2006)
Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo
Kinh-Tung T. Nguyen et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
Night work and breast cancer risk: A systematic review and meta-analysis
SP Megdal et al.
EUROPEAN JOURNAL OF CANCER (2005)
Benign breast disease and the risk of breast cancer
LC Hartmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer
A Boulay et al.
CLINICAL CANCER RESEARCH (2005)
Milk, dairy fat, dietary calcium, and weight gain - A longitudinal study of adolescents
CS Berkey et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle
BB Dokken et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Second primary breast cancer after Hodgkin's disease
A Horwich et al.
BRITISH JOURNAL OF CANCER (2004)
Body size and breast cancer risk:: Findings from the european prospective investigation into cancer and nutrition (EPIC)
PH Lahmann et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Plasma prolactin concentrations and risk of postmenopausal breast cancer
SS Tworoger et al.
CANCER RESEARCH (2004)
Breast cancer risk associated with ovulation-stimulating drugs
LA Brinton et al.
HUMAN REPRODUCTION (2004)
The PIK3CA gene is mutated with high frequency in human breast cancers
KE Bachman et al.
CANCER BIOLOGY & THERAPY (2004)
Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
V Beral et al.
LANCET (2003)
Recreational physical activity and the risk of breast cancer in postmenopausal women - The Women's Health Initiative cohort study
A McTiernan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Ras proteins: Different signals from different locations
JF Hancock
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990
CE Land et al.
RADIATION RESEARCH (2003)
Alcohol, tobacco and breast cancer -: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease
V Beral et al.
BRITISH JOURNAL OF CANCER (2002)
Breast cancer in men
SH Giordano et al.
ANNALS OF INTERNAL MEDICINE (2002)
Oral contraceptives and the risk of breast cancer
PA Marchbanks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
K Yu et al.
ENDOCRINE-RELATED CANCER (2001)
Inhibition of GSK-3 selectively reduces glucose-B-phosphatase and phosphoenolpyruvate carboxykinase gene expression
PA Lochhead et al.
DIABETES (2001)
Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses' Health Study
GA Colditz et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
More about: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
C Magnusson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
